BIOMAT Database Logo BIOMAT Database Logo

[Danazol treatment of myelodysplastic syndromes]. 1989

J Vicente, and J Feliu, and I Cebreiros, and M González Barón

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000754 Anemia, Refractory, with Excess of Blasts Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. Leukemia, Smoldering,RAEB,RAEM,Refractory Anemia with Excess of Blasts,Leukemia, Smouldering,Leukemias, Smoldering,Smoldering Leukemia,Smoldering Leukemias,Smouldering Leukemia

Related Publications

J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol treatment of myelodysplastic syndromes.
April 1991, British journal of haematology,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
[Treatment of myelodysplastic syndromes with danazol].
January 1988, Archivos de investigacion medica,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol in the treatment of myelodysplastic syndromes.
October 1987, European journal of haematology,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol for myelodysplastic syndromes.
September 1993, British journal of haematology,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol and myelodysplastic syndromes.
March 1986, Annals of internal medicine,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol therapy in myelodysplastic syndromes.
January 1992, Haematologica,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review.
December 2023, Oncology (Williston Park, N.Y.),
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Therapeutic efficacy of danazol in myelodysplastic syndromes.
September 1988, European journal of cancer & clinical oncology,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
[Danazol in the treatment of acute leukemic transformation of myelodysplastic syndromes].
November 1987, Medicina clinica,
J Vicente, and J Feliu, and I Cebreiros, and M González Barón
Randomized study of danazol vs. placebo in myelodysplastic syndromes.
January 1989, Archivos de investigacion medica,
Copied contents to your clipboard!